KBC Group
MLAB icon

KBC Group’s Mesa Laboratories MLAB Stock Holding History

KBC Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-263
Closed -$29K – 1888
2024
Q1 		$29K Hold
263
– – ﹤0.01% 1780
2023
Q4 		$28K Hold
263
– – ﹤0.01% 1823
2023
Q3 		$28K Sell
263
-110
-29% -$14.1K ﹤0.01% 1817
2023
Q2 		$48K Sell
373
-59
-14% -$8.99K ﹤0.01% 1373
2023
Q1 		$75K Hold
432
– – ﹤0.01% 1288
2022
Q4 		$72K Hold
432
– – ﹤0.01% 1310
2022
Q3 		$61K Hold
432
– – ﹤0.01% 1342
2022
Q2 		$88K Buy
+432
New +$94.6K ﹤0.01% 1276

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KBC Group's MLAB Position: Q2 2024 in Review

KBC Group sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 263 shares — an estimated $29K sold.

KBC Group first reported a position in MLAB in Q2 2022 and held it in 8 quarters. The position peaked at $88K in Q2 2022. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

  • KBC Group reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 263 Mesa Laboratories shares in Q2 2024, an estimated $29K.
  • KBC Group first reported a position in Mesa Laboratories in Q2 2022 and held it in 8 quarters.
  • KBC Group's Mesa Laboratories position peaked at $88K in Q2 2022.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.